Leukemia or blood cancer is a type of cancer that affects the ability of a person’s to fight infection. In leukemia, tumors are formed in blood-forming tissues including bone marrow. There are different types of leukemia including acute myeloid leukemia, lymphoblastic leukemia, and chronic lymphocytic leukemia. The most common symptoms of leukemia are easy bleeding, bruising, fatigue, weight loss, etc.
Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/528
Increasing incidences of cancer is expected to drive growth of the global leukemia therapeutics market during the forecast period. According to the Centre for Disease Control (CDC), around 14.1 million people were diagnosed with cancer in 2012, resulting in around 8.2 million fatalities. Around 19.3 million new cases of cancer are projected to be diagnosed by 2025.
Furthermore, growing product approvals by regulatory authorities is expected to propel the global leukemia therapeutics market growth over the forecast period. For instance, in November 2018, Pfizer Inc., received the U.S. Food and Drug Administration (FDA) approval for glasdegib (DAURISMO), the Hedgehog pathway inhibitor for the treatment of adults suffering from acute myeloid leukemia (AML). Similarly, in April 2017, Novartis Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for midostaurin (Rydapt) for the treatment of adult diagnosed with FLT3-mutated acute myeloid leukemia (AML).
Among regions, North America is expected to witness significant growth in the global leukemia therapeutics market, followed by Europe. This is owing to prolonged exposure to radiation leading to genetic mutations. According to Center for Disease Control and Prevention (CDC), in the U.S. around 45,360 people were diagnosed with leukemia in 2013, leading to 23,549 fatalities (13,625 men and 9,924 women). The condition is more prevalent among men than women. Leukemia makes up about 3% of all new cancer cases. Furthermore, according to the World Cancer Research Fund, one third of the cancer cases occur in economically developed economies such as U.S. and Europe, owing to lack of physical activity, obesity, and/or poor nutrition. Furthermore, around 90% of the leukemia occur in the middle age and develop with the aging.
Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/528
Moreover, Asia Pacific is expected to exhibiting high growth rate in the global leukemia therapeutics market over the forecast period. This is owing to high unmet medical needs. Besides, adoption of different inorganic growth strategies is expected to boost the regional market growth in the near future. For instance, in April 2019, Astellas Pharma Inc., a Japan based company, and Concerto HealthAI, a real-world data (RWD), artificial intelligence (AI) technology and outcomes Science Company collaboratively launched Real-World Evidence (RWE) initiative on Acute Myeloid Leukemia in order to improve treatment of patients with suffering from FLT3 mutation-positive relapsed AML.
However, low diagnosis rate of leukemia and lack of proper healthcare facilities in few Asian and African countries is restraining growth of the leukemia therapeutics market in these regions.
Leukemia Therapeutics Market Taxonomy:
By Disease Condition:
Acute lymphocytic leukemia
Chronic lymphocytic leukemia
Acute myeloid leukemia
Chronic myeloid leukemia
Bone Marrow Transplant
Stem Cell Therapy
Key players in the Leukemia therapeutics market:
Some of the key players operating in the leukemia therapeutics market includes GlaxoSmithKline plc, Eisai C., Pfizer, Biogen, Celgene, Novartis AG, Genzyme Corporation, Roche, and Bristol Myers Squibb Company (BMS)
Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/528
Reasons to Purchase this Report
• Current and future of global Leukemia Therapeutics Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/528
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Leukemia Therapeutics Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Leukemia Therapeutics Industry Impact
Chapter 2 Global Leukemia Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Leukemia Therapeutics (Volume and Value) by Type
2.3 Global Leukemia Therapeutics (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Leukemia Therapeutics Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Leukemia Therapeutics Market Analysis
Chapter 6 East Asia Leukemia Therapeutics Market Analysis
Chapter 7 Europe Leukemia Therapeutics Market Analysis
Chapter 8 South Asia Leukemia Therapeutics Market Analysis
Chapter 9 Southeast Asia Leukemia Therapeutics Market Analysis
Chapter 10 Middle East Leukemia Therapeutics Market Analysis
Chapter 11 Africa Leukemia Therapeutics Market Analysis
Chapter 12 Oceania Leukemia Therapeutics Market Analysis
Chapter 13 South America Leukemia Therapeutics Market Analysis
Chapter 14 Company Profiles and Key Figures in Leukemia Therapeutics Business
Chapter 15 Global Leukemia Therapeutics Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027